A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease
Clinical trial NCT06088979 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06088979
- Sponsor
- Tourmaline Bio, Inc., a Novartis Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-19
- Primary completion
- 2026-09-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.